Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

Xuan Wu,1,* Wenhua Liang,1,* Xue Hou,1,* Zhong Lin,2 Hongyun Zhao,1 Yan Huang,1 Wenfeng Fang,1 Yuanyuan Zhao,1 Jingxun Wu,3 Yunpeng Yang,1 Chong Xue,1 Zhihuang Hu,1 Jing Zhang,1 Jianwei Zhang,1 Yuxiang Ma,1 Ting Zhou,1 Tao Qin,1 Li Zhang1 1State Key Laboratory of Oncology in South China, Department...

Full description

Bibliographic Details
Main Authors: Wu X, Liang WH, Hou X, Lin Z, Zhao HY, Huang Y, Fang WF, Zhao YY, Wu JX, Yang YP, Xue C, Hu ZH, Zhang J, Zhang JW, Ma YX, Zhou T, Qin T, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2013-10-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/serum-proteomic-study-on-egfr-tkis-target-treatment-for-patients-with--a14740

Internet

http://www.dovepress.com/serum-proteomic-study-on-egfr-tkis-target-treatment-for-patients-with--a14740

Similar Items